ScreenerHero
ERFEurofins Scientific SE
EPA · FR · Healthcare · Diagnostics & Research · eurofins.com
69.32EUR+0.26%Mkt Cap: 13.05B $P/E: 27.20

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and huma…

Industry Peers

Diagnostics & Research
Screen all
vs Diagnostics & Research
P/E
Avg
P/B
Avg
Div Yield
Avg
1M Perf
Avg
TMO
Thermo Fisher Scientific Inc.
$194.52BUSDP/E 28.7
DHR
Danaher Corporation
$140.09BUSDP/E 38.3
LONN
Lonza Group Ltd
$45.77BUSDP/E 44.2
IDXX
IDEXX Laboratories, Inc.
$44.00BUSDP/E 41.0
NTRA
Natera, Inc.
$40.00BUSD
WAT
Waters Corporation
$37.24BUSDP/E 48.3
A
Agilent Technologies, Inc.
$36.91BUSDP/E 26.2
IQV
IQVIA Holdings Inc
$34.55BUSDP/E 25.7
ILMN
Illumina, Inc.
$28.55BUSDP/E 34.4
MTD
Mettler-Toledo International, Inc.
$26.44BUSDP/E 30.8
DGX
Quest Diagnostics Incorporated
$23.88BUSDP/E 23.8
LH
Laboratory Corporation of America Holdings
$23.53BUSDP/E 25.4
GH
Guardant Health, Inc.
$22.27BUSD
MEDP
Medpace Holdings, Inc.
$15.92BUSDP/E 35.1
RVTY
Revvity Inc. Common Stock
$12.69BUSDP/E 54.7
CRL
Charles River Laboratories International, Inc.
$11.11BUSD
BIM
bioMerieux S.A.
$8.90BUSDP/E 20.8
TWST
Twist Bioscience Corp.
$6.18BUSD
BLLN
BillionToOne Inc. Class A Common Stock
$5.54BUSDP/E 222.9
RDNT
RadNet, Inc.
$5.41BUSD
SHC
Sotera Health Company
$5.11BUSDP/E 43.7
VCYT
Veracyte, Inc.
$4.55BUSDP/E 52.9
DIA
DiaSorin S.p.A.
$3.76BUSDP/E 26.4
ADPT
Adaptive Biotechnologies Corp.
$3.39BUSD
GRAL
GRAIL Inc. Common Stock
$2.97BUSD
WGS
GeneDx Holdings Corp. Class A Common Stock
$2.00BUSD
NEO
NeoGenomics, Inc.
$1.97BUSD
VIMIAN
Vimian Group AB (publ)
$1.53BUSDP/E 38.8
DIA
Diagnostyka S.A.
$1.55BUSDP/E 23.4
CDNA
CareDx, Inc.
$1.51BUSD
PSNL
Personalis, Inc.
$1.43BUSD
OPK
OPKO Health, Inc.
$1.15BUSD
CBAV
Clinica Baviera, S.A.
$1.03BUSDP/E 21.7
CSTL
Castle Biosciences, Inc.
$731.26MUSD
LBIRD
Lumibird SA
$616.40MUSDP/E 40.2
FLGT
Fulgent Genetics, Inc.
$592.15MUSD
MYGN
Myriad Genetics, Inc.
$565.74MUSD
VOX
Voxel S.A.
$305.89MUSDP/E 3.1
EDT
Spectral Medical Inc.
$284.20MUSD
BDSX
Biodesix, Inc.
$227.72MUSD
IMDX
Insight Molecular Diagnostics Inc. Common Stock
$185.35MUSD
SLV
Selvita S.A.
$145.94MUSD
FONR
FONAR Corporation
$120.20MUSDP/E 19.1
XGN
Exagen, Inc.
$109.69MUSD
ALECR
Eurofins-Cerep SA
$94.30MUSDP/E 18.1
BIOPOR
BioPorto A/S
$81.49MUSD
PANG
Pangaea Oncology, S.A.
$58.94MUSD
PRPO
Precipio, Inc.
$45.15MUSD
ABDX
Abingdon Health Plc
$33.01MUSD
NN6
NanoRepro AG
$29.61MUSD
GDR
genedrive plc
$26.77MUSD
SENZA
SenzaGen AB
$18.53MUSD
VRCI
Verici Dx plc
$14.37MUSD
IMMNOV
Immunovia AB
$12.48MUSD
BMX
BioMaxima S.A.
$10.08MUSDP/E 63.3
ALPRE
Predilife S.A.
$9.98MUSD
XWEL
XWELL Inc. Common Stock
$9.04MUSD
PRM
Proteome Sciences plc
$7.31MUSD
OBD
Oxford BioDynamics Plc
$6.05MUSD
NDRA
ENDRA Life Sciences Inc.
$5.99MUSD
BIAF
bioAffinity Technologies Inc. Common Stock
$5.21MUSD
AVCR
Avricore Health Inc.
$5.06MUSD
ISPC
iSpecimen Inc. Common Stock
$3.79MUSD
JUMP
Leveljump Healthcare Corp.
$3.86MUSDP/E 2.8
TELO
Telo Genomics Corp.
$3.29MUSD
NOTV
Inotiv, Inc.
$2.79MUSD
PROGEN
Prostatype Genomics AB (publ)
$1.87MUSD
PRPH
ProPhase Labs, Inc.
$1.12MUSD
MBI-H
Med BioGene Inc.
$314.2KUSDP/E Infinity
TTOO
T2 Biosystems, Inc.
$56.1KUSD
Indicators:|

Key Statistics

Company
Market Cap13.05B $
Enterprise Value17.16B $
Revenue (TTM)7.93B $
Gross Profit5.40B $
Net Income (TTM)516.09M $
Revenue/Share44.11 USD
Last Price69.32 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees65.7K
CountryFR
SectorHealthcare
IndustryDiagnostics & Research
ISINFR0014000MR3
Valuation
P/E (Trailing)27.20
P/E (Forward)14.69
PEG1.05
EV/EBITDA10.85
EV/Revenue2.16
P/S1.63
P/B3.42
EPS (TTM)2.55
EPS (Forward)4.67
52W Range
54.8674% of range74.32
52W High74.32 EUR
52W Low54.86 EUR
Profitability
Gross Margin68.12%
Oper. Margin13.25%
EBITDA Margin19.95%
Profit Margin6.51%
ROE10.45%
ROA4.32%
Growth
Revenue Growth4.30%
Earnings Growth28.90%
Cash Flow & Leverage
Operating CF1.52B $
CapEx (TTM)907.39M $
FCF Margin6.75%
FCF Yield4.10%
Net Debt3.95B $
Net Debt/EBITDA2.50
Balance Sheet
Debt/Equity0.98
Current Ratio1.09
Quick Ratio1.00
Book Value/Sh20.05 EUR
Cash/Share4.495 EUR
Dividends
Fwd Div Rate0.7200 EUR
Trail. Div Rate0.7200 EUR
Div. Yield1.06%
5Y Avg Yield0.48%
Payout Ratio23.53%
Ex-Div DateApr 28, 2026
Pay Date—
Splits
Last Split10:1
Split DateNov 19, 2020
Analyst Consensus
Rating2.5 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)71.03 EUR
Upside (mean)+2.5%
Target Range48.00 EUR – 86.00 EUR
€48.00+2.5% to mean€86.00
# Analysts14
Ownership
Shares Out.173.22M
Float112.46M
Insiders36.50%
Institutions35.12%
Technical
SMA 5062.57 (+10.8%)
SMA 20063.32 (+9.5%)
Beta0.85
S&P 52W Chg20.05%
Avg Vol (30d)197.35K
Avg Vol (10d)320.39K
Technical Indicators
RSI (14)72.3
MACD1.6723
MACD Signal1.1942
MACD Hist.+0.4780
BB Upper70.40 EUR
BB Middle65.59 EUR
BB Lower60.79 EUR
BB Width14.64%
ATR (14)1.424 EUR
Vol Ratio (20d)0.34x